JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Noble, F.
Right arrow Articles by Cox, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Noble, F.
Right arrow Articles by Cox, B. M.

Vol. 283, Issue 2, 557-565, 1997

The Role of Dopaminergic Systems in Opioid Receptor Desensitization in Nucleus Accumbens and Caudate Putamen of Rat After Chronic Morphine Treatment1

Florence Noble2 and Brian M. Cox

Department of Pharmacology, Uniformed Services University of the Health Sciences, Bethesda, Maryland

Morphine treatment of rats (60-70 mg/kg/day, 7 days) reduced delta  opioid receptor-mediated inhibition of adenylyl cyclase activity in caudate putamen without any change in regulation by µ receptors. Earlier studies suggested that dopamine D1 and µ opioid receptors that regulate adenylyl cyclase are expressed preferentially by striato-nigral neurons, whereas adenosine A2a and delta 1 opioid receptors are expressed preferentially by striato-pallidal neurons. Chronic morphine treatment also resulted in a reduction of dopamine D2 receptor-mediated inhibition of A2a receptor-stimulated adenylyl cyclase. Treatment with a D2 receptor antagonist (eticlopride; 1 mg/kg/day) for 7 days reduced D1 receptor stimulation of adenylyl cyclase. In contrast, chronic treatment with a D1 receptor antagonist R(+)-7-chloro-8-dihydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine HCL (SCH 23390; 2.5 mg/kg/day) resulted in a reduction of delta 1 and delta 2 opioid inhibition of adenylyl cyclase, with no change in the inhibitory activity of a µ agonist. The inhibitory activity of the D2 agonist quinelorane against adenosine A2a-activated enzyme was also reduced by this treatment. Thus chronic D1 blockade, like chronic morphine treatment, appears to cause a selective impairment of the regulation of adenylyl cyclase in A2a receptor-expressing striato-pallidal neurons. D2 receptor activation appears to play an important role in the desensitization of delta  receptors, because concurrent administration of the D2 antagonist eticlopride with morphine prevented the densitization of delta  and D2 receptors. Similar results were obtained in nucleus accumbens, which suggests a role for D2 receptor desensitization in the adaptive response of this brain region to chronic morphine.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Psychosom. Med.Home page
M. Elovainio, M. Jokela, M. Kivimaki, L. Pulkki-Raback, T. Lehtimaki, N. Airla, and L. Keltikangas-Jarvinen
Genetic Variants in the DRD2 Gene Moderate the Relationship Between Stressful Life Events and Depressive Symptoms in Adults: Cardiovascular Risk in Young Finns Study
Psychosom Med, June 1, 2007; 69(5): 391 - 395.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
M.-R. Zarrindast, M. Farahmandfar, P. Rostami, and A. Rezayof
The influence of central administration of dopaminergic and cholinergic agents on morphine-induced amnesia in morphine-sensitized mice
J Psychopharmacol, January 1, 2006; 20(1): 59 - 66.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Yao, P. Fan, Z. Jiang, W. S. Mailliard, A. S. Gordon, and I. Diamond
Addicting drugs utilize a synergistic molecular mechanism in common requiring adenosine and Gi-{beta}{gamma} dimers
PNAS, November 25, 2003; 100(24): 14379 - 14384.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. J. Sim-Selley, D. E. Selley, L. J. Vogt, S. R. Childers, and T. J. Martin
Chronic Heroin Self-Administration Desensitizes {micro} Opioid Receptor-Activated G-Proteins in Specific Regions of Rat Brain
J. Neurosci., June 15, 2000; 20(12): 4555 - 4562.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.